CM Life Sciences III Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.
IPO Year:
Exchange: NASDAQ
Business combination with CM Life Sciences III results in approximately $1.3 billion in cash proceedsCombined company to trade on Nasdaq Global Market under ticker "EQRX" NEW YORK and CAMBRIDGE, Mass., Dec. 17, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences III (NASDAQ:CMLT, CMLTW, CMLTU))), a life science-focused special purpose acquisition company, or SPAC, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, and EQRx, Inc., a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, today announced the completion of their business combination. The business combination was approved by CM Life S
The month of December shows an increasing number of SPAC deal votes. SPAC merger votes can act as a catalyst, as the votes complete the last step in the merger process and change the company over to a new name and ticker that can help build recognition. Several former SPACs also saw wide swings in their share price after being de-SPAC-ed if they receive heavy redemption and have a low float for shares available. December SPAC Merger Calendar: Dec. 1: Aldel Financial Inc (NYSE:ADF) and Hagerty: Auto insurance company Hagerty specializes in providing insurance for classic cars and vehicles. Dec. 2: 890 5th Avenue Partners (NASDAQ:ENFA) and BuzzFeed: Media company BuzzFeed owns brands that i
4/A - EQRx, Inc. (0001843762) (Issuer)
3 - EQRx, Inc. (0001843762) (Issuer)
3 - EQRx, Inc. (0001843762) (Issuer)
4 - EQRx, Inc. (0001843762) (Issuer)
3 - EQRx, Inc. (0001843762) (Issuer)
4 - EQRx, Inc. (0001843762) (Issuer)
4 - EQRx, Inc. (0001843762) (Issuer)
4 - EQRx, Inc. (0001843762) (Issuer)
4 - EQRx, Inc. (0001843762) (Issuer)
4 - EQRx, Inc. (0001843762) (Issuer)
SC 13D - EQRx, Inc. (0001843762) (Subject)
SC 13D - EQRx, Inc. (0001843762) (Subject)
SC 13G - CM Life Sciences III Inc. (0001843762) (Subject)
EFFECT - EQRx, Inc. (0001843762) (Filer)
424B3 - EQRx, Inc. (0001843762) (Filer)
S-1 - EQRx, Inc. (0001843762) (Filer)
8-K - EQRx, Inc. (0001843762) (Filer)
425 - CM Life Sciences III Inc. (0001843762) (Subject)
425 - CM Life Sciences III Inc. (0001843762) (Subject)
425 - CM Life Sciences III Inc. (0001843762) (Subject)
EFFECT - CM Life Sciences III Inc. (0001843762) (Filer)
424B3 - CM Life Sciences III Inc. (0001843762) (Filer)
S-4/A - CM Life Sciences III Inc. (0001843762) (Filer)